| Literature DB >> 35887539 |
Miriam Duci1, Erich Cosmi2, Pierpaolo Zorzato2, Ambrogio Pietro Londero3, Giovanna Verlato4, Eugenio Baraldi4, Eugenio Ragazzi5, Francesco Fascetti Leon1, Silvia Visentin2.
Abstract
Antenatal factors play a role in NEC pathogenesis. This study aimed to investigate the predictive value of fetal ductus venosus doppler (DV) for NEC in fetal growth restriction fetuses (FGRF) and to assess the predictive accuracy of IG21 and Fenton curves in NEC development. Data from FGRF, postnatal findings, and Doppler characteristics were collected between 2010 and 2020 at a single center. Patients were then divided into two groups (i.e., with and without NEC). Bivariate and multivariate analyses were performed. We identified 24 cases and 30 controls. Absent or reversed end-diastolic flow (AREDF) and increased resistance in the DV were more impaired in cases (p < 0.05). Although the median birthweight was not different, the Fenton z-score was lower in NEC (p < 0.05). Fetal cardiopulmonary resuscitation, synchronized intermittent mandatory ventilation, neonatal respiratory distress, persistent patent ductus arteriosus (PDA), and inotropic support were more frequent in the NEC group. Furthermore, NEC patients had lower white blood cells (WBC) (p < 0.05). The predictive model for NEC (model 4), including Fenton z-score, WBC, PDA, and DV had an AUC of 84%. Fetal Doppler findings proved effective in predicting NEC in FGR. The Fenton z-score was the most predictive factor considering the fetal growth assessment showing high sensitivity.Entities:
Keywords: Doppler flow velocimetry; fetal growth restriction; necrotizing enterocolitis; predictive values; premature
Year: 2022 PMID: 35887539 PMCID: PMC9323983 DOI: 10.3390/jpm12071042
Source DB: PubMed Journal: J Pers Med ISSN: 2075-4426
Figure 1Flowchart.
Population description.
| Controls (29) | NEC (24) |
| |
|---|---|---|---|
| Maternal characteristics and pregnancy management | |||
| Maternal age (years) | 34.00 (32.00–36.00) | 36.50 (31.75–39.00) | 0.299 |
| Nulliparity | 41.38% (12/29) | 58.33% (14/24) | 0.219 |
| Medically assisted procreation | 13.79% (4/29) | 16.67% (4/24) | 0.771 |
| RDS prophylaxis | 62.07% (18/29) | 75.00% (18/24) | 0.315 |
| Delivery by CS | 96.55% (28/29) | 87.50% (21/24) | 0.214 |
| Pregnancy and fetal characteristics | |||
| Pre-eclampsia | 31.03% (9/29) | 41.67% (10/24) | 0.422 |
| Gestational diabetes | 3.45% (1/29) | 4.17% (1/24) | 0.891 |
| Premature preterm rupture of membranes | 13.79% (4/29) | 12.50% (3/24) | 0.890 |
| Chorioamnionitis | 6.90% (2/29) | 8.33% (2/24) | 0.844 |
| Maternal Doppler | |||
| Mean uterine arteries PI > 95th percentile | 41.38% (12/29) | 62.50% (15/24) | 0.126 |
| Bilateral uterine arteries notching | 24.14% (7/29) | 45.83% (11/24) | 0.097 |
| Fetal Doppler | |||
| MCA PI< 5th percentile | 41.38% (12/29) | 54.17% (13/24) | 0.353 |
| UA AREDF | 17.24% (5/29) | 41.67% (10/24) | <0.05 |
| DV PI > 95th percentile | 10.34% (3/29) | 41.67% (10/24) | <0.05 |
Abbreviation List: necrotizing enterocolitis (NEC); respiratory distress syndrome (RDS); Cesarean delivery (CS); middle cerebral arterial Doppler (MCA); absent or reversed end-diastolic flow (AREDF), ductus venosus Doppler (DV); umbilical artery (UA); pulsatility index (PI).
Neonatal characteristics.
| Controls (29) | NEC (24) |
| |
|---|---|---|---|
| Neonatal characteristics | |||
| Neonatal male sex | 51.72% (15/29) | 66.67% (16/24) | 0.272 |
| Gestational age at delivery | |||
| Days | 213 (192–230) | 196 (185–211) | 0.100 |
| Weeks | 30.43 (27.43–32.86) | 27.93 (26.39–30.18) | 0.100 |
| Apgar score at 5 min | 8.00 (7.00–8.00) | 8.00 (7.00–8.00) | 0.857 |
| Apgar score at 10 min | 8.00 (8.00–9.00) | 8.00 (8.00–9.00) | 0.698 |
| Cord blood pH | 7.31 (7.28–7.34) | 7.32 (7.28–7.35) | 0.802 |
| Birthweight (grams) | 880.00 (650.00–1270.00) | 747.50 (558.75–943.75) | 0.186 |
| Birthweight (Fenton z-score) | −1.66 (−2.74–1.16) | −3.09 (−4.21–1.88) | <0.05 |
| Birthweight (Fenton MoM) | 0.70 (0.63–0.77) | 0.73 (0.64–0.78) | 0.681 |
| Birthweight (IG21 z-score) | −1.68 (−2.11–1.14) | −1.61 (−2.05–1.43) | 0.639 |
| Birthweight (IG21 MoM) | 0.75 (0.65–0.82) | 0.74 (0.65–0.90) | 0.754 |
| Fetal blood sample at birth | |||
| Hb (g/L) | 153.00 (145.00–170.00) | 159.00 (143.00–168.50) | 0.897 |
| Platelets (×109/L) | 183.00 (133.00–225.00) | 178.00 (107.50–224.00) | 0.587 |
| WBC (×109/L) | 6860.00 (5530.00–10,470.00) | 4290.00 (2535.00–6360.00) | <0.05 |
| Fetal cardio-pulmonary resuscitation | 44.83% (13/29) | 83.33% (20/24) | <0.05 |
| Fetal tracheal intubation at birth | 27.59% (8/29) | 37.50% (9/24) | 0.441 |
| Fetal tracheal intubation after birth | 3.45% (1/29) | 0.00% (0/24) | 0.358 |
| Neonatal ventilation within the first 24 h of life | |||
| 1 Spontaneous breathing | 24.14% (7/29) | 16.67% (4/24) | 0.504 |
| 2 Synchronized intermittent mandatory ventilation | 41.38% (12/29) | 70.83% (17/24) | <0.05 |
| 3 Nasal continuous positive airway pressure | 10.34% (3/29) | 8.33% (2/24) | 0.803 |
| 4 High-flow nasal cannula oxygen | 20.69% (6/29) | 4.17% (1/24) | 0.077 |
| 5 High-frequency oscillatory ventilation | 3.45% (1/29) | 0.00% (0/24) | 0.358 |
| Neonatal RDS | 48.28% (14/29) | 79.17% (19/24) | <0.05 |
| Surfactant use | 62.07% (18/29) | 79.17% (19/24) | 0.177 |
| Apnea of prematurity | 34.48% (10/29) | 45.83% (11/24) | 0.400 |
| IVH | 34.48% (10/29) | 25.00% (6/24) | 0.454 |
| Neonatal sepsis | 3.45% (1/29) | 0.00% (0/24) | 0.358 |
| Respiratory acidosis | 27.59% (8/29) | 41.67% (10/24) | 0.281 |
| PDA | 24.14% (7/29) | 54.17% (13/24) | <0.05 |
| PFO | 34.48% (10/29) | 45.83% (11/24) | 0.400 |
| Inotropic support | 6.90% (2/29) | 25.00% (6/24) | 0.067 |
| Enteral nutrition duration (days) | 1.00 (1.00–1.00) | 2.00 (1.00–3.00) | 0.188 |
| Type of Enteral nutrition HM (%) | 26/29 (89.65) | 20/24 (83.33%) | 0.6881 |
Abbreviation List: necrotizing enterocolitis (NEC); intergrowth-21st (IG21); multiple of median (MoM); white blood cell (WBC); hemoglobin (Hb); respiratory distress syndrome (RDS); intraventricular hemorrhage (IVH); persistent patent ductus arteriosus (PDA); patent foramen ovale (PFO); human milk (HM).
Predictivity of parameters according to nominal logistic regression followed by ROC analysis for univariate models.
| OR (*) | p (ŧ) | AUC (*) | Specificity (*) (**) | Sensitivity (*) (**) | |
|---|---|---|---|---|---|
| Maternal and fetal Doppler (prenatal) | |||||
| Bilateral uterine artery notching | 2.6593 (0.8256–8.5657) | 0.101 | 61% (48–74%) | 76% (50–100%) | 46% (25–100%) |
| UA AREDF | 3.4286 (0.9728–12.084) | 0.055 | 62% (50–74%) | 83% (66–97%) | 42% (21–62%) |
| DV PI > 95th percentile | 6.1905 (1.46–26.2484) | 0.013 | 66% (54–77%) | 90% (79–100%) | 42% (21–62%) |
| Maternal and pregnancy characteristics | |||||
| Maternal age (years) | 1.0468 (0.935–1.172) | 0.427 | 58% (42–75%) | 86% (66–97%) | 46% (25–71%) |
| Nulliparity | 1.9833 (0.6618–5.9438) | 0.221 | 58% (45–72%) | 59% (0–100%) | 58% (0–100%) |
| Gestational age at delivery (days) | 0.9833 (0.961–1.0061) | 0.150 | 63% (48–79%) | 52% (31–97%) | 79% (29–96%) |
| Post-natal characteristics | |||||
| Fetal cardio-pulmonary resuscitation | 6.15385 (1.67835–22.56368) | 0.006 | 69% (57–81%) | 55% (38–72%) | 83% (67–96%) |
| PDA | 3.71429 (1.15316–11.96363) | 0.028 | 65% (52–78%) | 76% (59–90%) | 54% (33–75%) |
| Inotropic support | 4.5 (0.81564–24.827) | 0.084 | 59% (49–69%) | 93% (79–100%) | 25% (8–50%) |
| Birthweight (grams) | 0.9993 (0.9981–1.0006) | 0.289 | 61% (45–76%) | 38% (28–97%) | 88% (25–96%) |
| Birthweight (Fenton z-score) | 0.6682 (0.4713–0.9474) | 0.024 | 68% (54–83%) | 48% (24–93%) | 83% (42–100%) |
| Birthweight (Fenton z-score ≤ −1.62) | 4.6667 (1.2753–17.0772) | 0.020 | 66% (54–78%) | 48% (31–66%) | 83% (67–96%) |
| Newborn WBC (×109/L) | 0.9998 (0.9996–0.9999) | 0.015 | 74% (60–88%) | 79% (59–100%) | 71% (38–92%) |
| Newborn WBC ≤ 5255 × 109/L | 9.3095 (2.6465–32.7479) | 0.001 | 75% (63–87%) | 79% (62–93%) | 71% (50–88%) |
(*) (95% CI); (**) Calculated considering the ROC curve best threshold of the model; (ŧ) The p-values indicate the statistical significance of each parameter considered, determined with Likelihood-ratio test. Abbreviation List: umbilical artery (UA); absent or reversed end-diastolic flow (AREDF), ductus venosus Doppler (DV); pulsatility index (PI); persistent patent ductus arteriosus (PDA); white blood cell (WBC).
Predictivity of parameters according to nominal logistic regression followed by ROC analysis for multivariate models.
| OR (*) | AUC (*) | Specificity (*) (**) | Sensitivity (*) (**) | ||
|---|---|---|---|---|---|
| Model 1 ( | 68% (55–81%) | 90% (69–100%) | 42% (21–71%) | ||
| UA AREDF | 2.0569 (0.5089–8.3144) | 0.312 | |||
| DV PI > 95th percentile | 4.6982 (1.0161–21.7226) | 0.048 | |||
| Model 2 ( | 68% (54–83%) | 41% (31–83%) | 96% (62–100%) | ||
| Birthweight (Fenton z-score ≤ −1.62) | 4.3918 (1.1861–16.2626) | 0.027 | |||
| Birthweight (grams) | 0.9995 (0.9982–1.0008) | 0.469 | |||
| Model 3 ( | 82% (71–94%) | 76% (59–90%) | 88% (71–100%) | ||
| Birthweight (Fenton z-score ≤ −1.62) | 3.5051 (0.7672–16.0132) | 0.106 | |||
| Newborn WBC ≤ 5255 × 109/L | 6.3635 (1.6871–24.0027) | 0.006 | |||
| PDA | 3.0366 (0.7747–11.9019) | 0.111 | |||
| Model 4 ( | 84% (72–95%) | 72% (55–93%) | 92% (71–100%) | ||
| Birthweight z-score Fenton ≤ −1.62 | 2.9388 (0.6127–14.0957) | 0.178 | |||
| Newborn WBC ≤ 5255 × 109/L | 5.362 (1.3667–21.0366) | 0.016 | |||
| PDA | 2.8815 (0.7208–11.5184) | 0.134 | |||
| DV PI > 95th percentile | 2.3867 (0.4509–12.633) | 0.306 |
(*) (95% CI); (**) Calculated considering the ROC curve best threshold of the model; (ŧ) The p-values indicate the statistical significance of each parameter considered, determined with Likelihood-ratio test; (ŧŧ) This p-value is the significance for whole model determined with chi-squared test. Abbreviation List: umbilical artery (UA); absent or reversed end-diastolic flow (AREDF), ductus venosus Doppler (DV); pulsatility index (PI); white blood cell (WBC). Persistent patent ductus arteriosus (PDA).